| Chemical & Physical Properties | |
|---|---|
| CAS Number | 946414-94-4 |
| Catalog No. | 2A-2181932 |
| Chinese Name | 纳武单抗 |
| Storage Condition | -20℃, avoid light |
| Application | Nivolumab (anti-PD-1) is a programmed death receptor-1 (PD-1) that blocks human IgG4 antibodies and is used to treat advanced (metastatic) non-small cell lung cancer [1]. |
| SMILES | CC(C=CS(C)(=O)=O)CC(=O)c1cccc2c1NC(C)(C)CC2C.CC1=CC(C)(C)Nc2c(C(=O)CC(C)C=CS(C)(=O)=O)cccc21.CC1=CC(C)(C)Nc2c(C(=O)CCC=CS(C)(=O)=O)cccc21.CC1CC(C)(C)Nc2c(C(=O)CCC=CS(C)(=O)=O)cccc21 |
| InChI Key | VSTHRBNUEGPUOM-UHFFFAOYSA-N |
| NACRES Code | NA.24 |
| UNSPSC | 12352203 |
| Transport Info | Product name: Nivolumab (anti-PD-1) |
| Related Products in API & Advanced Intermediates | ||
|---|---|---|
| 2-epi-Emtricitabine | 145416-34-8 | 2A-3181907 |
| 5-Fluoro ent-LaMivudine Acid D-Menthol Ester | 764659-79-2 | 2A-3181908 |
| EMtricitabine Carboxylic Acid | 1238210-10-0 | 2A-3181910 |
| 7β-Fulvestrant | 407577-53-1 | 2A-3181912 |
| ipilimumab | 477202-00-9 | 2A-0202043 |
| mepolizumab | 196078-29-2 | 2A-2181939 |
| Fulvestrant 9-Sulfone | 98008-06-1 | 2A-3181947 |
| Fulvestrant (ICI 182780) S enantiomer | 1316849-17-8 | 2A-3181949 |
| Fulvestrant (ICI 182780) R enantiomer | 1807900-80-6 | 2A-3181950 |
| 1,2-Dihydro Fluticasone Propionate | 105613-90-9 | 2A-3181957 |
| Browse all API & Advanced Intermediates products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA
EN
SDS